The company reported a consolidated loss of Rs 68.47 crore ($8.21 million) for the quarter ended March 31, compared with a loss of Rs 159 crore a year ago
The board has recommended a dividend of Rs 32 per equity share on face value of Rs 10 each for the year ended 31 March 2024, subject to approval of members at 99th Annual General Meeting
On a sequential basis, the company exhibited a 22.83 per cent increase in revenue, the PAT also rose by 53.57 per cent
Zee Entertainment Enterprises Ltd on Friday reported a consolidated net profit of Rs 13.35 crore in the March quarter. The company had posted a consolidated net loss of Rs 196.03 crore in the same period of the previous fiscal, Zee Entertainment Enterprises (ZEEL) said in a regulatory filing. Consolidated total income in the quarter stood at Rs 2,185.29 crore as against Rs 2,126.35 crore in the corresponding period a year ago, it added. In the fourth quarter of FY24, domestic advertising revenue grew 10.6 per cent year-on-year driven by the continued recovery in macro advertising environment and spending pickup by FMCG clients, while subscription revenue growth was driven by pick up in linear subscription, the company said in an investor presentation. Total expenses in the fourth quarter were lower at Rs 2,043.76 crore as compared to Rs 2,083.35 crore in the year-ago period. The board of directors has recommended a final dividend of Re 1 per equity share having face value of Re 1
JSW Steel Q4 FY24 results: The company recommended a final dividend of Rs 7.30 per fully paid-up equity share of Re.1 each for the year ended on March 31, 2024
Bandhan Bank's provisions and contingencies jumped to Rs 1,774 crore from Rs 735 crore a year earlier
TV Today Network Ltd on Friday reported nearly two-fold rise in consolidated net profit to Rs 11.46 crore in the March quarter on the back of higher revenue from television and other media operations. The company had posted a consolidated net profit of Rs 5.85 crore in the year-ago period, TV Today Network said in a regulatory filing. Consolidated revenue from operations in the quarter under review stood at Rs 252.79 crore as against Rs 217.14 crore in the corresponding period a year ago, it added. Television and other media operations posted revenue of Rs 247.37 crore in the fourth quarter as against Rs 213.25 crore in the corresponding period a year ago. Radio broadcasting revenue was at Rs 5.42 crore in the January-March period, up from Rs 3.89 crore a year earlier, the company said. Total expenses in the fourth quarter were higher at Rs 241.3 crore as compared to Rs 206.89 crore in the year-ago period. The board of directors has recommended a final dividend of Rs 8.50 per equ
Indian generic drugmakers, which draw a significant share of revenue from the crucial U.S. market, are recovering from the effects of eroding prices in the largest drug market in the world
LT Foods, owner of basmati rice brands 'Daawat' and 'Royal', on Friday posted a 14 per cent jump in consolidated net profit at Rs 150.24 crore for the fourth quarter of fiscal 2023-24 on robust sales. The company's profit stood at Rs 131.81 crore a year earlier. Total income rose to Rs 2,091.73 crore during the January-March quarter of 2023-24, from Rs 1,834.95 crore in the same period a year ago, the company said in a regulatory filing. Expenses remained higher at Rs 1,898.46 crore versus Rs 1,685.92 crore a year earlier. For the full fiscal year 2023-24, LT Foods reported a 41.35 per cent increase in net profit at Rs 597.59 crore, compared with Rs 422.75 crore in the previous year. Total income rose to Rs 7,822.05 crore from R 6,978.81 crore a year earlier. Commenting on the performance, LT Foods Managing Director Ashwani Arora said the company has delivered stellar growth in revenue and profitability for yet another year, despite facing a challenging external environment. The
Stock markethighlights on May 17, 2024: M&M, JSW Steel, Ultratech Cement, Kotak Bank, ITC, Maruti Suzuki, NTPC, and Tata Motors were the top gainers on the Sensex
GlaxoSmithKline Pharmaceuticals Ltd on Friday reported a 46 per cent increase in consolidated net profit at Rs 194.48 crore in the fourth quarter ended March 31, on the back of higher sales. The company had posted a net profit of Rs 133.43 crore in the corresponding quarter of the previous fiscal, GlaxoSmithKline Pharmaceuticals (GSK Pharma) said in a regulatory filing. Consolidated revenue from operations in the quarter under review stood at Rs 929.8 crore as against Rs 787.45 crore in the year-ago period, it added. Total expenses in the fourth quarter were higher at Rs 691.41 crore as compared to Rs 635.54 crore in the same period a year ago. The board has recommended a dividend of Rs 32 per equity share on the face value of Rs 10 each for the year ended March 31, subject to approval of members at upcoming annual general meeting, the company said. For the fiscal ended March 31, 2024 net profit was at Rs 589.96 crore as compared to Rs 610.69 crore in the preceding year, the compa
In the past six trading days, the index has outperformed by surging 5.4 per cent, as compared to 2.4 per cent rise in the Nifty 50.
eClerx plans to allocate up to Rs 385 crore for its buyback, equivalent to 24.98 per cent of the total paid-up equity share capital and 18.38 per cent of free reserves
Q4 FY24 company results: Delhivery, JSW Steel, Godrej Industries, Bandhan Bank and many more companies are slated to release their fourth-quarter earnings
PB Fintech block deal news: Yashish Dahiya, chairman and CEO, and Alok Bansal, vice chairman and whole-time director, have sold partial stakes in the company
Mahindra & Mahindra's market capitalisation touched Rs 3.18 trillion in Friday's intra-day trade on the BSE.
Latest rise was due to low base in Q4 FY23 as a result of supply disruptions
Farm business PAT grew 2 per cent in FY24 when industry volumes declined
The telco's finance cost increased to Rs 6,280.3 crore in Q4, shooting up by 25.5 per cent from Rs 6,284 crore in the same quarter of the previous year
Biocon has re-appointed Kiran Mazumdar Shaw as an Executive Director of the company for a further period of 5 years starting April 2025